Top Markets
#1 Black Phoenix Black Phoenix +365.41%
#2 Islamic Coin Islamic Coin +158.18%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.15%
#5 Akedo Akedo +35.88%
#6 Acurast Acurast +29.21%
#7 BasedHype BasedHype +27.99%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.34%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +20.05%
Coin of the day
Black Phoenix Black Phoenix
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Amarantus BioScience Holdings, Inc. Amarantus BioScience Holdings, Inc.

Amarantus BioScience Holdings, Inc.

AMBS
Helyezés a részvények között #41184
Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm,... Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating innovative diagnostic tools and therapeutic solutions. Its primary focus areas encompass neurological disorders, psychiatric conditions, eye-related ailments (ophthalmology), and regenerative medicine. The company's diagnostic pipeline includes the LymPro test, a blood-based diagnostic designed to detect Alzheimer's disease by analyzing lymphocyte proliferation, and MSPrecise, a proprietary DNA sequencing assay aimed at identifying individuals with multiple sclerosis. On the therapeutic front, Amarantus is advancing Eltoprazine, a small molecule drug targeting both Levadopa-Induced Dyskinesia in Parkinson's patients and attention deficit hyperactivity disorders (ADHD). Additionally, they are developing a mesencephalic-astrocyte-derived neurotrophic factor (MANF) for treating conditions modeled in animals, such as retinitis pigmentosa and retinal artery occlusion. Amarantus also maintains several specialized platforms: NuroPro, a diagnostic platform dedicated to neurodegenerative diseases with an initial application in Parkinson's; BC-SeraPro, an oncology diagnostic platform specifically for breast cancer; and the PhenoGuard platform, designed for discovering new neurotrophic factors. Beyond these, the company is progressing with Engineered Skin Substitute (ESS), a cell therapy-based product for autologous skin replacement, currently in mid-stage clinical development for severe, life-threatening burns. The company has established a collaborative research and development agreement with both the U.S. Army Institute of Surgical Research and Rutgers University. Established in 2008, Amarantus BioScience Holdings, Inc., which previously operated as Amarantus Bioscience, Inc. until its name change in April 2013, is headquartered in New York, New York.
Részvényárfolyam
$0.0001
Utolsó szinkronizálás: 2026-08-11
Piaci kapitalizáció
$36.84K
Változás (1 nap)
0.00%
Változás (1 év)
-66.67%
Ország
US
Kereskedés Amarantus BioScience Holdings, Inc. (AMBS)

Kategória

Healthcare
Amarantus BioScience Holdings, Inc. (AMBS) részvényárfolyamának története
Legmagasabb napi záróár: $0.00 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $0.00 ekkor: 2010-09-01
Amarantus BioScience Holdings, Inc. részvényárfolyamának története 2010 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) 0.00%
2025 -45.33%
2024 -92.14%
2023 -34.21%
2022 -85.44%
2021 56.94%
2020 -54.01%
2019 -24.76%
2018 -77.87%
2017 235.71%
2016 -95.77%
2015 -94.85%
2014 -99.02%
2013 49,751,484,054.67%
2012 -60.30%
2011 3,461.02%
2010 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $745.48 9.02%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.24 16.81%
BE